Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model-Reference-Cited by-全球学者库

Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model

Published:2016-12-07 Issue:5 Volume:41 Page:452-460
ISSN:0160-564X
Container-title:Artificial Organs
language:en
Short-container-title:Artificial Organs

Author:

Wei Wei¹,Liu Yiwei¹,Zhang Qiang²,Wang Yangming²,Zhang Xiaoling¹,Zhang Hao¹

Affiliation:

1. State Key Laboratory for Cardiovascular Diseases, Center for Pediatric Cardiac Surgery, Key Laboratory of Cardiac Regenerative Medicine; National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing China

2. Beijing Key Laboratory of Cardiometabolic Molecular Medicine; Institute of Molecular Medicine, Peking University; Beijing China

Funder

National Natural Science Foundation of China

Program for Distinguish Professor in PUMC

Publisher

Wiley

Subject

Biomedical Engineering,General Medicine,Biomaterials,Medicine (miscellaneous),Bioengineering

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aor.12801/fullpdf

Reference20 articles.

1. Examining efficacy of “TAT-less” delivery of a peptide against the L-type calcium channel in cardiac ischemia-reperfusion injury;Clemons;ACS Nano,2013

2. Prevention of myocardial intracellular edema induced by St. Thomas’ Hospital cardioplegic solution;Drewnowska;J Mol Cell Cardiol,1991

3. Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery;Suleiman;Perfusion,2011

4. Propofol cardioplegia: a single-center, placebo-controlled, randomized controlled trial;Rogers;J Thorac Cardiovasc Surg,2015

5. Phase III Trial of Dantonic (T89) Capsule to Prevent and Treat Stable Angina (CAESA) https://clinicaltrials.gov/ct2/show/NCT01659580 2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation;Frontiers in Cell and Developmental Biology;2023-01-18

2. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery;Biomedicine & Pharmacotherapy;2023-01

3. The potential of plant extracts in cell therapy;Stem Cell Research & Therapy;2022-09-14

4. Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes;Stem Cells Translational Medicine;2022-08-26

5. Cellular and Engineered Organoids for Cardiovascular Models;Circulation Research;2022-06-10